RaySearch Laboratories AB (publ)
STO:RAY B

Watchlist Manager
RaySearch Laboratories AB (publ) Logo
RaySearch Laboratories AB (publ)
STO:RAY B
Watchlist
Price: 204.5 SEK 0.25%
Market Cap: 7B SEK
Have any thoughts about
RaySearch Laboratories AB (publ)?
Write Note

RaySearch Laboratories AB (publ)
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

RaySearch Laboratories AB (publ)
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
RaySearch Laboratories AB (publ)
STO:RAY B
Free Cash Flow
kr246.6m
CAGR 3-Years
33%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ContextVision AB
OSE:CONTX
Free Cash Flow
kr35.5m
CAGR 3-Years
68%
CAGR 5-Years
N/A
CAGR 10-Years
34%
M
Mentice AB
STO:MNTC
Free Cash Flow
kr29.5m
CAGR 3-Years
78%
CAGR 5-Years
52%
CAGR 10-Years
N/A
O
Ortivus AB
STO:ORTI B
Free Cash Flow
-kr11.1m
CAGR 3-Years
N/A
CAGR 5-Years
-53%
CAGR 10-Years
N/A
Sectra AB
STO:SECT B
Free Cash Flow
kr75.6m
CAGR 3-Years
-37%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
K
Kontigo Care AB
STO:KONT
Free Cash Flow
-kr8.3m
CAGR 3-Years
N/A
CAGR 5-Years
-226%
CAGR 10-Years
N/A
No Stocks Found

RaySearch Laboratories AB (publ)
Glance View

Market Cap
7B SEK
Industry
Health Care

RaySearch Laboratories AB is a medical technology company, which engages in the development of software solutions for improved radiation therapy of cancer. The company is headquartered in Stockholm, Stockholm. The company markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. As of December 31, 2011, 15 of the Company’s products were launched, including the software platform ORBIT (optimization of radiation therapy beams by iterative technique), which is available in its main products, and is a non-clinical system which functions as a research and development environment. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.

RAY B Intrinsic Value
219.97 SEK
Undervaluation 7%
Intrinsic Value
Price

See Also

What is RaySearch Laboratories AB (publ)'s Free Cash Flow?
Free Cash Flow
246.6m SEK

Based on the financial report for Dec 31, 2023, RaySearch Laboratories AB (publ)'s Free Cash Flow amounts to 246.6m SEK.

What is RaySearch Laboratories AB (publ)'s Free Cash Flow growth rate?
Free Cash Flow CAGR 3Y
33%

Over the last year, the Free Cash Flow growth was 107%. The average annual Free Cash Flow growth rates for RaySearch Laboratories AB (publ) have been 33% over the past three years .

Back to Top